Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Breast Neoplasms × Magnetic Resonance Spectroscopy × Clear all

Phase

Status

Sponsor Class

OTHER 86 NIH 16 NETWORK 4 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Prostatic Hyperplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Motor Activity 1 Breast Neoplasms 1 Bone Metastases 1

Interventions

Tamoxifen 9 Docetaxel 7 Trastuzumab 6 Letrozole 6 Gemcitabine 6 Exercise 6 Paclitaxel 5 Indocyanine Green 5 Cyclophosphamide 5 Control Groups 5 exemestane 4 Doxorubicin 4 Carboplatin 4 Capecitabine 4 Anastrozole 4 dalpiciclib 3 Vinorelbine 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Cisplatin 3 pyrotinib 2 pertuzumab 2 ferumoxides 2 Zoledronic Acid 2 Tablets 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02701348 2021-08-06

BARONET

NHS Tayside

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡